Interleukin 2 response inhibition following donor specific transfusions given with azathioprine
Tyler, J.D.; Anderson, C.B.; Sicard, G.A.
Transplantation Proceedings 19(1 Part 3): 2258-2261
1987
ISSN/ISBN: 0041-1345 PMID: 3547923 Document Number: 304606
Document emailed within 1 workday
Related Documents
Jaskłowska-Englisz, M.; Olszewski, W.L. 1994: Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected Transplantation Proceedings 26(6): 3463Bordes-Aznar, J.; Odor, A.; Dib-Kuri, A.; Gabilondo, F.; Kasep, J.; Peña, J.C.; Herrera-Acosta, J.; Chávez-Peón, F. 1987: Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation Transplantation Proceedings 19(1 Pt 3): 2276-2277
Sintnicolaas, K.; Vriesendorp, H.M.; Sizoo, W.; Stenfert Kroese, W.F.; Haije, W.G.; Hop, W.C.; Abels, J.; Löwenberg, B. 1981: Delayed alloimmunisation by random single donor platelet transfusions. A randomised study to compare single donor and multiple donor platelet transfusions in cancer patients with severe thrombocytopenia Lancet 1(8223): 750-754
Bartlett, S.T.; Ward, R.E. 1989: Donor specific transfusions in rodent pancreatic transplantation Transplantation Proceedings 21(1 Part 1): 1185-1186
Matsumoto, T.; Sakagami, K.; Orita, K. 1987: Role of donor specific blood transfusions in prolongation of kidney graft survival Transplantation Proceedings 19(1 Part 3): 2264-2267
Shapira, Z.; Yussim, A.; Shmueli, D.; Mahinson, A.; Reichenthal, E.; Servadio, C. 1987: Renal retransplantation from living related donors using donor specific blood transfusions Transplantation Proceedings 19(1 Part 3): 2280-2281
Sijpkens, Y.W.; Koep, L.J.; Persijn, G.G.; Van der Werf, B.A. 1984: Pros and cons of donor-specific blood transfusions in living related kidney transplantation Netherlands Journal of Medicine 27(1): 1-5
Christiaans, M.H.; van Hooff, J.P.; Nieman, F.; van den Berg-Loonen, E.M. 1999: HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome Transplantation 67(7): 1029-1035
Sabbaga, E.; Ianhez, L.E.; Chocair, P.R.; Azevedo, L.S.; Sarturi, P.S.; de Goes, G.M. 1985: Kidney transplants from living nonrelated donors: an analysis of 87 cases, including 20 cases with specific blood transfusions from the donor Transplantation Proceedings 17(2): 1741-1745
Mottram, P.L.; Mirisklavos, A.; Clunie, G.J. 1985: Cyclosporine and murine responses to alloantigens: effects of cyclosporine and donor-specific transfusions on delayed hypersensitivity reactions and murine skin allografts Transplantation Proceedings 17(2): 1646-1649
Divanian, K. 1986: Antigen-specific inhibition of donor cell activity in the graft vs. host reaction Eksperimentalna Meditsina i Morfologiia 25(4): 47-49
Greger, B.; Pressler, H.; Hopt, U.T.; Schareck, W.D.; Müller, G.H.; Reis, H.J.; Bockhorn, H. 1987: Immunohistochemical findings, idiotypic inhibition and clinical outcome in patients developing donor-specific antibodies after kidney transplantation Transplantation Proceedings 19(5): 4286-4288
Medzihradsky, J.L.; Klein, C.; Elion, G.B. 1982: Differential interference by azathioprine and 6-mercaptopurine with antibody-mediated immunoregulation: synergism of azathioprine and antibody in the control of an immune response Journal of Immunology 129(1): 145-149
Matsue, K.; Harada, M.; Shiobara, S.; Okada, K.; Kondo, K.; Ueda, M.; Nakao, S.; Misawa, T.; Ohtake, S.; Hattori, K. 1983: Inhibition of donor's mixed lymphocyte culture and phytohemagglutinin response by chimeric mononuclear cells of an allogenic marrow transplant patient Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 46(3): 767-771
Opelz, G. 1981: The effect of transfusions in related donor kidney transplantation Transplantation 31(5): 404
Kaplan, C.; Niaudet, P.; Gagnadoux, M.F.; Bacri, J.L.; Reznikoff, M.F.; Muller, J.Y.; Broyer, M. 1985: Intrafamilial renal transplantation in children after donor blood transfusions Presse Medicale 14(27): 1455-1458
Goss, J.A.; Nakafusa, Y.; Yu, S.; Flye, M.W. 1993: Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection Transplantation Proceedings 25(1 Part 1): 286-288
Arima, T.; Lehmann, M.; Flye, M.W. 1997: Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen Transplantation 63(2): 284-292
Sheil, A.G.; Disney, A.P.; Mathew, T.H.; Amiss, N.; Excell, L. 1991: Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA Transplantation Proceedings 23(1 Part 2): 1111-1112
Liu, W.J.; Chiang, C.H.; Huang, T.Y. 1988: The influences of serum IgE-specific suppressor factor (IgE-TsF), interleukin-2(IL-2), and interleukin-2 receptor (IL-2R) by hyposensitization to children with bronchial asthma Gaoxiong Yi Xue Ke Xue Za Zhi 4(6): 364-371